Zobrazeno 1 - 7
of 7
pro vyhledávání: '"M. T. Díaz-Puente"'
Autor:
Jose I. Mayordomo, M. T. Díaz-Puente, E. López Martín, C. Mendiola, Luis Paz-Ares, Pilar Lianes, Marta López-Brea, Fernando Rivera, Maria D. Garcia-Prats, Hernán Cortés-Funes
Publikováno v:
Annals of Oncology. 5:225-231
Summary From 1978 to 1992, 276 patients (pts) with MGCT were treated in our institution. Forty-three of the pts were female (15,5%). Median age at diagnosis was 20 years (newborn-70). Histology was dysgerminoma (D) in 14 pts (including 2 anaplastic D
Autor:
Fernando Rivera, Francisco J. Martínez-Tello, Montserrat Lopez-Carreira, Maria D. Garcia-Prats, Jose I. Mayordomo, Manuel Muñoz, Hernán Cortés-Funes, M. T. Díaz-Puente, Claudio Ballestín
Publikováno v:
Tumori. 80(5)
A 57-year-old man was admitted with complaints of progressive anorexia, weight loss and right flank pain. He had been treated for basal-cell carcinoma of the skin 19 years before. On physical examination, eight moles in the face, back and left thigh
Autor:
E. López, H. Cortes-Funes, Marta López-Brea, Fernando Rivera, M. T. Díaz-Puente, M. P. Lianes, L. Paz-Ares, S. Alonso, Jose I. Mayordomo
Publikováno v:
Cancer Treatment An Update ISBN: 9782817807676
Febrile neutropenia (FN) is the second most frequent cause of death in patients receiving chemotherapy [1]. Mortality of FN remains about 5–10 % in spite of modern antibiotic regimens, and moreover the human and financial cost are high [2, 3, 4]. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1b5029f0d2243982df5a92b85def8f1
https://doi.org/10.1007/978-2-8178-0765-2_186
https://doi.org/10.1007/978-2-8178-0765-2_186
Autor:
M. T. Díaz-Puente, Luis Paz-Ares, Fernando Rivera, Hernán Cortés-Funes, J. Passas, Pilar Lianes, Cesar Mendiola, P. Costas
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 4(2)
Summary Background Despite standard treatment, surgery and/or radiotherapy, most patients with muscle invasive bladder carcinoma die early of distant metastasis. CMV chemotherapy has demonstrated a high response rate with moderate toxicity in advance
Autor:
C. C. L. Paz-Ares, A. Rodriguez, C. Gravalos, H. Cortés-Funes, M. T. Díaz-Puente, J. Passas, Isabel Sevilla, P. Lianes
Publikováno v:
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy ISBN: 9782817807843
Following reports of significant antitumor activity against metastatic and primary sites of TCC with new chemotherapy (CT) regimens (CMV, M-VAC), we started, in March 1987, a prospective study with neo-adjuvant CMV (Cisplatin, Methotrexate, Vinblasti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d2ca24ed1e0a577cf84c41432cbb976
https://doi.org/10.1007/978-2-8178-0782-9_29
https://doi.org/10.1007/978-2-8178-0782-9_29
Autor:
M. T. Díaz-Puente, Luis Paz-Ares, Maria D. Garcia-Prats, Jose I. Mayordomo, Hernán Cortés-Funes, Pilar Lianes
Publikováno v:
Journal of Clinical Oncology. 12:1737-1738
Publikováno v:
JNCI Journal of the National Cancer Institute. 85:1251-1252